Fluid Biopsy Market Size, Share and Growth Outlook, 2026: Analysis By Biomarker Type (Circulating Tumor Cells , Circulating Tumor DNA , Cell-free DNA , Extracellular Vesicles), By Technology (Next-Generation Sequencing , Digital PCR , Real-Time PCR, Microarray & qPCR), By Sample Type (Blood , Urine, Saliva, Cerebrospinal Fluid), By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Pancreatic Cancer), By End User (Reference Laboratories, Hospital & Physician Labs, Academic & Research Centers, CROs & Biopharma) Companies, and Country Forecast, 2021 to 2034
Global Fluid Biopsy Market size is forecast to increase from $13.66 Billion in 2026 to $31.94 Billion in 2034 at a CAGR of 11.2% between 2026 and 2034.